Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Thea Anine Strøm Halden"'
Autor:
Amin M. Ussif, Anders Åsberg, Thea Anine Strøm Halden, Espen Nordheim, Anders Hartmann, Trond Jenssen
Publikováno v:
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Abstract Background The use of HbA1c ≥6.5% for diagnosis of diabetes has been challenged for post-transplantation diabetes mellitus (PTDM) also known as new onset diabetes after transplantation (NODAT) due to a low sensitivity early after renal tra
Externí odkaz:
https://doaj.org/article/ac1d32a7c6be4087a1af91313446a081
Autor:
Thea Anine Strøm Halden, Sabine Leh, Hans-Peter Marti, Anders Åsberg, Janka Bábíčková, Anne Kipp, Jessica Furriol, Trond Jenssen, Bjørn Egil Vikse, Sigrid Nakken
Publikováno v:
Nephrology Dialysis Transplantation. 36
Background and Aims Diabetes mellitus, either preexisting or developing after kidney transplantation remains a crucial clinical problem. The aim of this study is to compare the proteome of histologically normal glomeruli from normoglycemic (NG), T2DM
Autor:
Rune Horneland, Thea Anine Strøm Halden, Kåre I. Birkeland, Dag Olav Dahle, Trond Jenssen, Anders Hartmann, Espen Nordheim, Anders Åsberg
Publikováno v:
Clinical Transplantation. 34
This is the peer reviewed version of the following article: Nordheim, E., Dahle, D. O., Halden, T., Birkeland, K. I., Åsberg, A., Hartmann, A., ... Jenssen, T. G. (2020). Endothelial function after pancreas transplantation - A single‐center observ
Autor:
Thea Anine Strøm Halden, Trond Jenssen, Anders Åsberg, Dag Olav Dahle, Ivar Eide, Anders Hartmann
Publikováno v:
Transplantation. 101:1282-1289
Previous reports indicate that posttransplantation diabetes mellitus (PTDM) is associated with overall renal graft loss, but not death-censored graft loss.In this single-center retrospective cohort study of 2749 adult Norwegian renal transplant recip
Autor:
Thea Anine Strøm Halden, Babickova Janka, Anders Aasberg, Jessica Furriol, Sabine Leh, Trond Jenssen, Hans-Peter Marti, Ann Kipp, Sigrid Nakken, Bjørn Egil Vikse
Publikováno v:
Nephrology Dialysis Transplantation. 34
Autor:
Thea Anine Strøm Halden, Trond Jenssen, Espen Nordheim, Anders Åsberg, Amin Ussif, Anders Hartmann
Publikováno v:
BMC Nephrology
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
BMC Nephrology, Vol 20, Iss 1, Pp 1-6 (2019)
Background The use of HbA1c ≥6.5% for diagnosis of diabetes has been challenged for post-transplantation diabetes mellitus (PTDM) also known as new onset diabetes after transplantation (NODAT) due to a low sensitivity early after renal transplantat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ab1a84275ac25d586108fd1650502bf
https://hdl.handle.net/10037/15769
https://hdl.handle.net/10037/15769
Autor:
Jan Brox, Jens Bollerslev, Ida Robertsen, Karsten Midtvedt, Anders Hartmann, Kine Eide Kvitne, Thea Anine Strøm Halden, Laavanyaah Rajakumar, Trond Jenssen, Anders Åsberg
OBJECTIVE Sodium–glucose cotransporter 2 (SGLT2) inhibitors have lately become the recommended treatment in patients with type 2 diabetes and high cardiovascular risk. Patients with posttransplant diabetes mellitus (PTDM) also have high cardiovascu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a198c9b83c269e9af569b41afc880062
http://hdl.handle.net/10852/76332
http://hdl.handle.net/10852/76332
Autor:
Dag Olav Dahle, Anders Åsberg, Anna Varberg Reisæter, Thea Anine Strøm Halden, Anders Hartmann, Ivar Eide, Trond Jenssen
Publikováno v:
Transplant International. 29:568-578
Current diagnostic criteria for post-transplantation diabetes mellitus (PTDM) are either fasting plasma glucose ≥7.0 mmol/l (≥126 mg/dl) or postchallenge plasma glucose ≥11.1 mmol/l (≥200 mg/dl) 2 h after glucose administration [oral glucose
Autor:
Dag Olav Dahle, Ivar Eide, Anders Hartmann, Anders Åsberg, Thea Anine Strøm Halden, Trond Jenssen, Anna Varberg Reisæter
Publikováno v:
Transplantation. 99:629-635
Background Posttransplant diabetes mellitus (PTDM) is usually detected 2 to 3 months after transplantation by fasting plasma glucose (fPG) ≥ 7.0 mmol/L (≥ 126 mg/dL) and/or 2 hr post-challenge plasma glucose ≥ 11.1 mmol/L (≥ 200 mg/dL) during
Publikováno v:
Nephrology Dialysis Transplantation. 29:926-933
Background New-onset diabetes after transplantation (NODAT) is a common complication after renal transplantation. There are limited available oral drugs to treat hyperglycaemia in this population owing to reduced renal function, potential interaction